Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
78,755,591
-
Share change
-
-435,144
-
Total reported value
-
$259,051,008
-
Put/Call ratio
-
7.4%
-
Price per share
-
$3.29
-
Number of holders
-
93
-
Value change
-
-$1,519,992
-
Number of buys
-
45
-
Number of sells
-
45
Institutional Holders of ACHILLION PHARMACEUTICALS IN - COM (ACHN) as of Q1 2014
As of 31 Mar 2014,
ACHILLION PHARMACEUTICALS IN - COM (ACHN) was held by
93 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
78,755,591 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, LLC, QVT Financial LP, State Street Corp, VANGUARD GROUP INC, Capital World Investors, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., GOLDMAN SACHS GROUP INC, STATE OF WISCONSIN INVESTMENT BOARD, and BB BIOTECH AG.
This page lists
93
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.